Head Office: Delhi/NCR | Other Branches: Lucknow

In a recent preliminary study, afamelanotide (16 mg subcutaneous implant) along with Narrowband UVB has given promising results In Vitiligo - Here is the study report
In a recent preliminary study, afamelanotide (16 mg subcutaneous implant) along with Narrowband UVB has given promising results In Vitiligo - Here is the study report
Home/Case Studies

Category: Case Studies

Narrowband UVB Therapy for Vitiligo

Vitiligo is a chronic skin disorder that affects millions of individuals worldwide. The condition is characterized by the …

Continue with WhatsApp

x
+91
Consult Now Get a Call Back

Continue with Phone

x
+91